Skip to content

Advertisement

  • Case report
  • Open Access
  • Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Crizotinib in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma in the setting of renal insufficiency: a case report

Journal of Medical Case Reports201610:176

https://doi.org/10.1186/s13256-016-0963-y

Received: 27 May 2015

Accepted: 31 May 2016

Published: 14 June 2016

Back to article

Open Peer Review reports

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
27 May 2015 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
31 May 2016 Editorially accepted
14 Jun 2016 Article published 10.1186/s13256-016-0963-y

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Medicine, SUNY Upstate Medical University, Syracuse, USA
(2)
Division of Hematology/Oncology, Department of Medicine, SUNY Upstate Medical University, Syracuse, USA
(3)
Department of Radiology, SUNY Upstate Medical University, Syracuse, USA

Advertisement